GB201704892D0 - Improved vaccines - Google Patents
Improved vaccinesInfo
- Publication number
- GB201704892D0 GB201704892D0 GBGB1704892.7A GB201704892A GB201704892D0 GB 201704892 D0 GB201704892 D0 GB 201704892D0 GB 201704892 A GB201704892 A GB 201704892A GB 201704892 D0 GB201704892 D0 GB 201704892D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- improved vaccines
- vaccines
- improved
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1704892.7A GB201704892D0 (en) | 2017-03-28 | 2017-03-28 | Improved vaccines |
PCT/EP2017/071232 WO2018037045A1 (en) | 2016-08-23 | 2017-08-23 | Fusion peptides with antigens linked to short fragments of invariant chain (cd74) |
CN201780065538.2A CN109863169A (en) | 2016-08-23 | 2017-08-23 | The fusogenic peptide of antigen with the short-movie section for being connected to invariant chain (CD74) |
EP17768002.2A EP3504230A1 (en) | 2016-08-23 | 2017-08-23 | Fusion peptides with antigens linked to short fragments of invariant chain (cd74) |
MX2019002178A MX2019002178A (en) | 2016-08-23 | 2017-08-23 | Fusion peptides with antigens linked to short fragments of invariant chain (cd74). |
BR112019003462A BR112019003462A2 (en) | 2016-08-23 | 2017-08-23 | fusion protein, polynucleotide, viral vector, pharmaceutical composition, use of a fusion protein, polynucleotide, viral vector or pharmaceutical composition, and method for treating or preventing viral hepatitis b infection or viral hepatitis c infection |
CA3034124A CA3034124A1 (en) | 2016-08-23 | 2017-08-23 | Fusion peptides with antigens linked to short fragments of invariant chain (cd74) |
JP2019510818A JP7535852B2 (en) | 2016-08-23 | 2017-08-23 | Fusion peptide in which an antigen is linked to a small fragment of the invariant chain (CD74) |
US16/327,575 US11498956B2 (en) | 2016-08-23 | 2017-08-23 | Fusion peptides with antigens linked to short fragments of invariant chain(CD74) |
JP2022117354A JP2022166002A (en) | 2016-08-23 | 2022-07-22 | Fusion peptides with antigens linked to short fragments of invariant chain (cd74) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1704892.7A GB201704892D0 (en) | 2017-03-28 | 2017-03-28 | Improved vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201704892D0 true GB201704892D0 (en) | 2017-05-10 |
Family
ID=58687854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1704892.7A Ceased GB201704892D0 (en) | 2016-08-23 | 2017-03-28 | Improved vaccines |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201704892D0 (en) |
-
2017
- 2017-03-28 GB GBGB1704892.7A patent/GB201704892D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL268920A (en) | Peptide vaccines | |
GB201721011D0 (en) | No details | |
GB201518684D0 (en) | Vaccine | |
GB201410971D0 (en) | Vaccine | |
PL3185899T3 (en) | Improved hvt-vectored nd-ibd vaccine | |
EP3684343C0 (en) | Improved supraparticles | |
IL272526A (en) | Improved endoinulinases | |
GB201522132D0 (en) | Vaccine | |
GB201616904D0 (en) | Vaccine | |
GB201508099D0 (en) | Dengue vaccines | |
GB201801239D0 (en) | No details | |
GB201720890D0 (en) | No details | |
GB201709043D0 (en) | No details | |
GB201703529D0 (en) | Vaccine composition | |
GB201608821D0 (en) | Vaccines | |
LT3188755T (en) | Vaccine | |
GB201811382D0 (en) | Vaccine | |
GB201718538D0 (en) | u | |
GB201707210D0 (en) | Improved hitchlock | |
GB201417214D0 (en) | Vaccine | |
GB201704892D0 (en) | Improved vaccines | |
GB201712904D0 (en) | Vaccine | |
GB201807303D0 (en) | Glyconjugate vaccines | |
GB201707785D0 (en) | Vaccination | |
GB201704126D0 (en) | Vaccine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |